Rare diseases
Investigational molecules
Locations
A safety and efficacy study of SAR445399 in adults with moderate to severe hidradenitis suppurativa
BelgiumA study to evaluate the effectiveness of BI 1015550 in people with lung abnormalities and a family history of pulmonary fibrosis
BelgiumComparing ziconotide and a drug combination to standard medical management for patients with severe cancer pain
BelgiumA study of tirofiban and adenosine to treat small blood vessel damage in patients with ST-elevation myocardial infarction
FranceA study to evaluate the safety of ADX-038 in patients with complement-mediated kidney disease
ItalyA study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis
AustriaA study of ficerafusp alfa and nivolumab in patients with head and neck cancer who did not respond to platinum-based chemotherapy.
FranceA study to evaluate the effectiveness and safety of ursodeoxycholic acid in patients with hepatorenal polycystic diseases.
SpainA study of MK-1084 and a drug combination for patients with advanced or metastatic non-small cell lung cancer with KRAS G12C mutations.
GermanyA study to compare the effectiveness of rituximab and a placebo in patients with interstitial lung disease associated with rheumatoid arthritis
SwedenStudy of the safety and use of the Extroducer infusion catheter system for delivering gemcitabine to patients with unresectable locally advanced pancreatic cancer
SwedenEvaluating the effect of recombinant varicella zoster virus glycoprotein E on the risk of dementia in adults aged 76 years and older
FinlandTell us about your condition – we search every trial in Europe and connect you with the right site.
